UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:February 04,
Lexaria Bioscience (NASDAQ:LEXX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Lexaria Bioscience Charts.
Lexaria Bioscience (NASDAQ:LEXX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience Corp. News

Form DEF 14A - Other definitive proxy statements
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 17 February 2024 (2 months ago) • Edgar (US Regulatory)
Form D - Notice of Exempt Offering of Securities
Saturday 17 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Thursday 15 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 31 January 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)
Form POS AM - Post-Effective amendments for registration statement
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)
Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 13 January 2024 (4 months ago) • Edgar (US Regulatory)
Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
Friday 12 January 2024 (4 months ago) • GlobeNewswire Inc.

More Lexaria Bioscience Corp. News Articles